Sommer Patrick J, Schuster Sebastian, Goldhardt Oliver, Okamura Nobuyuki, Mueller-Sarnowski Felix, Scheifele Maximilian, Eckenweber Florian, Kreuzer Annika, Griessl Maria, Bartenstein Peter, Wegehaupt Thomas, Wolski Lucas, Priller Josef, Rominger Axel, Beyer Leonie, Grimmer Timo, Brendel Matthias
Center for Cognitive Disorders, Department of Psychiatry and Psychotherapy, Technical University of Munich, School of Medicine and Health, TUM University Hospital, Munich, Germany.
Department of Nuclear Medicine, Ludwig-Maximilian-University Munich, Munich, Germany; Institute of Diagnostic and Interventional Radiology and Neuroradiology, Munich Clinic Harlaching, Munich, Germany.
Neuroimage Clin. 2025 Apr 24;46:103789. doi: 10.1016/j.nicl.2025.103789.
Partial volume effects in positron emission tomography occur frequently in neurodegenerative diseases due to increasing cortical atrophy during the disease course, and fronto-temporal dementia is often characterized by severe atrophy. The aim of this study was to challenge partial volume effect correction (PVEC) in patients with nonfluent-agrammatic variant primary progressive aphasia (nfv-PPA) imaged with [F]-THK-5351 PET a marker of reactive neuroinflammatory astrogliosis as well as tau-binding.
Patients with nfv-PPA (n = 20) were imaged with [F]-THK-5351 PET accompanied by structural magnetic resonance tomography imaging (MRI). Region specific cortical grey matter volumes and standard uptake value ratios (SUVr) of the Hammers atlas were compared with eight healthy control (HC) (n = 8) data before and after performing region-based voxel-wise PVEC. We evaluated regional coefficients of variance (CoV) and the number of regions with significant [F]-THK-5351 PET signal differences between nfv-PPA and controls before and after PVEC. Additionally, a blinded visual read was performed by three nuclear medicine physicians (consensus) before and after PVEC.
Prior to PVEC, [F]-THK-5351 tracer uptake was significantly higher in the bilateral frontal cortex of patients with nfv-PPA when compared to HC (left > right), despite significant grey matter atrophy in the same brain regions in patients with nfv-PPA. SUVr differences between nfv-PPA and HC were further increased by PVEC in frontal brain regions, but group level variance increased in parallel and reduced the number of significant differences between SUVr of nfv-PPA and HC (uncorrected: 10 significant regions, CoV[nfv-PPA]: 20.8 % ± 4.7 %, CoV[HC]: 7.9 % ± 2.4 %/PVEC: 3 significant regions, CoV[nfv-PPA]: 28.4 % ± 8.9 %, CoV[HC]: 9.8 % ± 2.5 %). Sensitivity/specificity of the visual read for detection of nfv-PPA was 0.85/1.00 without PVEC and 0.85/0.75 with PVEC.
[F]-THK-5351 PET facilitates detection of pathological alterations in patients with nfvPPA with severe atrophy. PVEC increases quantitative SUVr differences between patients with nfv-PPA and HC but introduces a parallel increase of variance at the group level. Visual assessment of [F]-THK-5351 images in patients with nfv-PPA is impaired by PVEC due to loss of specificity and does not support the use of PVEC even in patients with severe atrophy.
在神经退行性疾病中,由于病程中皮质萎缩加剧,正电子发射断层扫描中的部分容积效应频繁出现,而额颞叶痴呆常以严重萎缩为特征。本研究的目的是对非流畅性语法变异型原发性进行性失语(nfv-PPA)患者进行[F]-THK-5351 PET成像时的部分容积效应校正(PVEC)提出质疑,[F]-THK-5351是反应性神经炎性星形胶质细胞增生以及tau结合的标志物。
对20例nfv-PPA患者进行[F]-THK-5351 PET成像,并伴有结构磁共振断层扫描成像(MRI)。在进行基于区域的体素级PVEC之前和之后,将哈默斯图谱的区域特异性皮质灰质体积和标准摄取值比率(SUVr)与8名健康对照(HC)(n = 8)的数据进行比较。我们评估了nfv-PPA与对照组在PVEC前后[F]-THK-5351 PET信号差异显著的区域的变异系数(CoV)和区域数量。此外,在PVEC前后由三名核医学医师进行了盲法视觉读片(达成共识)。
在PVEC之前,与HC相比,nfv-PPA患者双侧额叶皮质的[F]-THK-5351示踪剂摄取显著更高(左侧>右侧),尽管nfv-PPA患者在相同脑区存在显著的灰质萎缩。PVEC使额叶脑区nfv-PPA与HC之间的SUVr差异进一步增加,但组水平的方差同时增加,减少了nfv-PPA与HC的SUVr之间显著差异的数量(未校正:10个显著区域,CoV[nfv-PPA]:20.8%±4.7%,CoV[HC]:7.9%±2.4%/PVEC:3个显著区域,CoV[nfv-PPA]:28.4%±8.9%,CoV[HC]:9.8%±2.5%)。视觉读片检测nfv-PPA的敏感性/特异性在无PVEC时为0.85/1.00,在有PVEC时为0.85/0.75。
[F]-THK-5351 PET有助于检测患有严重萎缩的nfvPPA患者的病理改变。PVEC增加了nfv-PPA患者与HC之间的定量SUVr差异,但在组水平引入了方差的平行增加。PVEC导致nfv-PPA患者[F]-THK-5351图像的视觉评估因特异性丧失而受损,即使在严重萎缩的患者中也不支持使用PVEC。